The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as a leading core lab for remote patient monitoring (RPM)...
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe...
Yang Huang, Head of China Healthcare Research at J.P. Morgan, unpacks how favourable policies, demographic shifts, and global collaborations are shaping the future of biopharma and medtech investment in China. ...
This strategic collaboration aims to advance medical education and clinical training in laparoscopic and minimally invasive surgical techniques...
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial ...
Medtech firm unveils Axana®, a 50kg, AI-enhanced, portable MRI device that cuts stroke diagnosis time by over 90%—unlocking lifesaving treatment in the golden hour and opening an $8.9bn global market opportunity....
The Prinses Máxima Centre is the largest pediatric cancer centre in Europe, dedicated to integrating care and research to improve outcomes for children with cancer...
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites...
Improves p-wave signal detection up to 160%, helping clinicians identify atrial abnormalities to prevent future adverse cardiac events...
Robust 24-month complete response (CR) rate of 41.8 per cent observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment...
